Mustafa Ahmad Fikri Muhammad, Ab Mukmin Laila, Mazlan Mohd Zulfakar, Ghani Abdul Rahman Izaini, Wan Hassan Wan Mohd Nazaruddin, Hassan Mohamad Hasyizan
Department of Anaesthesiology and Intensive Care, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.
Hospital USM, Universiti Sains Malaysia, Kelantan, Malaysia.
Malays J Med Sci. 2024 Apr;31(2):142-152. doi: 10.21315/mjms2024.31.2.12. Epub 2024 Apr 23.
Severe traumatic brain injury (TBI) is a leading cause of disability worldwide and cerebral protection (CP) management might determine the outcome of the patient. CP in severe TBI is to protect the brain from further insults, optimise cerebral metabolism and prevent secondary brain injury. This study aimed to analyse the short-term Glasgow Outcome Scale (GOS) at the intensive care unit (ICU) discharge and a month after ICU discharge of patients post CP and factors associated with the favourable outcome.
This is a prospective cohort study from January 2021 to January 2022. The short-term outcomes of patients were evaluated upon ICU discharge and 1 month after ICU discharge using GOS. Favourable outcome was defined as GOS 4 and 5. Generalised Estimation Equation (GEE) was adopted to conduct bivariate GEE and subsequently multivariate GEE to evaluate the factors associated with favourable outcome at ICU discharge and 1 month after discharge.
A total of 92 patients with severe TBI with GOS of 8 and below admitted to ICU received CP management. Proportion of death is 17% at ICU discharge and 0% after 1 month of ICU discharge. Proportion of favourable outcome is 26.1% at ICU discharge and 61.1% after 1 month of ICU discharge. Among factors evaluated, age (odds ratio [OR] = 0.96; 95% CI: 0.94, 0.99; = 0.004), duration of CP (OR = 0.41; 95% CI: 0.20, 0.84; = 0.014) and hyperosmolar therapy (OR = 0.41; CI 95%: 0.21, 0.83; = 0.013) had significant association.
CP in younger age, longer duration of CP and patient not receiving hyperosmolar therapy are associated with favourable outcomes. We recommend further clinical trial to assess long term outcome of CP.
重型颅脑损伤(TBI)是全球致残的主要原因之一,脑保护(CP)管理可能决定患者的预后。重型TBI的CP旨在保护大脑免受进一步损伤,优化脑代谢并预防继发性脑损伤。本研究旨在分析CP治疗后患者在重症监护病房(ICU)出院时及出院后1个月的短期格拉斯哥预后量表(GOS),以及与良好预后相关的因素。
这是一项从2021年1月至2022年1月的前瞻性队列研究。患者的短期预后在ICU出院时及出院后1个月使用GOS进行评估。良好预后定义为GOS 4和5。采用广义估计方程(GEE)进行双变量GEE分析,随后进行多变量GEE分析,以评估ICU出院时及出院后1个月与良好预后相关的因素。
共有92例GOS评分为8分及以下的重型TBI患者入住ICU并接受CP管理。ICU出院时死亡率为17%,ICU出院1个月后死亡率为0%。ICU出院时良好预后的比例为26.1%,ICU出院1个月后为61.1%。在评估的因素中,年龄(优势比[OR]=0.96;95%可信区间:0.94,0.99;P=0.004)、CP持续时间(OR=0.41;95%可信区间:0.20,0.84;P=0.014)和高渗疗法(OR=0.41;95%可信区间:0.21,0.83;P=0.013)有显著关联。
年龄较小、CP持续时间较长且未接受高渗疗法的患者CP治疗预后良好。我们建议进一步开展临床试验以评估CP的长期疗效。